Acorda Therapeutics

ACOR

ACOR
Acorda Therapeutics Stock Quote
$2.40 -$0.01 -0.4%
BATS BZX Real Time Price as of October 14, 2019, 4:00 p.m. EDT View Interactive ACOR Charts

A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS.

News & Analysis: Acorda Therapeutics

The Fool has written over 100 articles on Acorda Therapeutics.

All

Market Moves

Earnings











Interactive Chart